Annual EBIT
-$55.45 M
-$20.20 M-57.32%
31 December 2023
Summary:
CG Oncology Common stock annual earnings before interest & taxes is currently -$55.45 million, with the most recent change of -$20.20 million (-57.32%) on 31 December 2023. CGON annual EBIT is now -347.60% below its all-time high of -$12.38 million.CGON EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$28.30 M
-$2.44 M-9.45%
30 September 2024
Summary:
CG Oncology Common stock quarterly earnings before interest & taxes is currently -$28.30 million, with the most recent change of -$2.44 million (-9.45%) on 30 September 2024. Over the past year, it has dropped by -$14.25 million (-101.49%). CGON quarterly EBIT is now -203.76% below its all-time high of -$9.31 million, reached on 01 December 2022.CGON Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$95.97 M
-$14.25 M-17.44%
30 September 2024
Summary:
CG Oncology Common stock TTM earnings before interest & taxes is currently -$95.97 million, with the most recent change of -$14.25 million (-17.44%) on 30 September 2024. Over the past year, it has dropped by -$50.57 million (-111.37%). CGON TTM EBIT is now -930.30% below its all-time high of -$9.31 million, reached on 01 December 2022.CGON TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.3% | -101.5% | -111.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CGON EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -347.6% | at low | -203.8% | at low | -930.3% | at low |
| 5 y | 5 years | -347.6% | at low | -203.8% | at low | -930.3% | at low |
| alltime | all time | -347.6% | at low | -203.8% | at low | -930.3% | at low |
CG Oncology Common Stock EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.30 M(+9.4%) | -$95.97 M(+17.4%) |
| June 2024 | - | -$25.85 M(+15.1%) | -$81.72 M(+19.8%) |
| Mar 2024 | - | -$22.47 M(+16.1%) | -$68.19 M(+23.0%) |
| Dec 2023 | -$55.45 M | -$19.36 M(+37.8%) | -$55.45 M(+22.1%) |
| Sept 2023 | - | -$14.04 M(+13.9%) | -$45.41 M(+44.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$12.33 M(+26.8%) | -$31.36 M(+64.8%) |
| Mar 2023 | - | -$9.72 M(+4.4%) | -$19.04 M(+104.4%) |
| Dec 2022 | -$35.25 M(+184.5%) | - | - |
| Dec 2022 | - | -$9.31 M | -$9.31 M |
| Dec 2021 | -$12.39 M | - | - |
FAQ
- What is CG Oncology Common stock annual earnings before interest & taxes?
- What is the all time high annual EBIT for CG Oncology Common stock?
- What is CG Oncology Common stock annual EBIT year-on-year change?
- What is CG Oncology Common stock quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CG Oncology Common stock?
- What is CG Oncology Common stock quarterly EBIT year-on-year change?
- What is CG Oncology Common stock TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CG Oncology Common stock?
- What is CG Oncology Common stock TTM EBIT year-on-year change?
What is CG Oncology Common stock annual earnings before interest & taxes?
The current annual EBIT of CGON is -$55.45 M
What is the all time high annual EBIT for CG Oncology Common stock?
CG Oncology Common stock all-time high annual earnings before interest & taxes is -$12.38 M
What is CG Oncology Common stock annual EBIT year-on-year change?
Over the past year, CGON annual earnings before interest & taxes has changed by -$20.20 M (-57.32%)
What is CG Oncology Common stock quarterly earnings before interest & taxes?
The current quarterly EBIT of CGON is -$28.30 M
What is the all time high quarterly EBIT for CG Oncology Common stock?
CG Oncology Common stock all-time high quarterly earnings before interest & taxes is -$9.31 M
What is CG Oncology Common stock quarterly EBIT year-on-year change?
Over the past year, CGON quarterly earnings before interest & taxes has changed by -$14.25 M (-101.49%)
What is CG Oncology Common stock TTM earnings before interest & taxes?
The current TTM EBIT of CGON is -$95.97 M
What is the all time high TTM EBIT for CG Oncology Common stock?
CG Oncology Common stock all-time high TTM earnings before interest & taxes is -$9.31 M
What is CG Oncology Common stock TTM EBIT year-on-year change?
Over the past year, CGON TTM earnings before interest & taxes has changed by -$50.57 M (-111.37%)